Vaccines, Blood & Biologics

RAGWITEK

STN: 125478
Proper Name: Short Ragweed Pollen Allergen Extract
Tradename: RAGWITEK
Manufacturer: Merck Sharp & Dohme Corp
Indication:

  • Immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen approved for use in adults 18 through 65 years of age.

Supporting Documents

Related Information

Page Last Updated: 02/12/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.